Fortune 500 Companies
Nasal spray for depression now FDA-approved as standalone treatment
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
As bird flu becomes a growing threat, Moderna is awarded $590M to develop mRNA pandemic influenza vaccines
No person-to-person spread has been detected, but that doesn’t mean an H5N1 avian influenza pandemic isn’t possible or even probable. ...
Brian Moynihan says big banks like BofA may have to adopt crypto payments, leading one wealth advisor to predict Bitcoin will hit $130K this year
Bitcoin could be propelled to a valuation of $130,000 in 2025 according to one wealth advisor, buoyed by positive sentiments ...
Netflix raises prices across subscriptions, promises increased ad growth: ‘2025 is the year that we transition from crawl to walk’
The streaming giant doubled ad revenue last year, and expects to double it again this year. Read More
Dell’s employees had 800 different gen AI ideas. Here’s how the PC maker winnowed the list to 8
In deciding which AI projects to pursue, Dell calculates the return on investment. Read More
Mark Zuckerberg is reportedly blaming former Meta exec Sheryl Sandberg for a company inclusivity initiative
Mark Zuckerberg is overhauling Meta’s DEI initiatives — and reportedly blaming his former COO, Sheryl Sandberg, for an old policy. ...
Lilly weight-loss pill orforglipron could get FDA approval in 2026, CEO Dave Ricks says
Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication ...
Trump has promised to ‘knock out’ pharmacy benefit managers. How the drug middlemen became a $557 billion industry that its customers love to hate
© 2024 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Wall Street’s changing of the guard is underway
JPMorgan and BlackRock reshuffled their leadership teams last week. Read More
Health-care investors bank on Congress snarling RFK Jr.’s plans
In spite of RFK Jr.’s wide-ranging plans, many Wall Street professionals believe the policy risk in health care is low. ...
